Loading...
Conjugated Retinoic Acid Receptor beta Rabbit mAb

C56343

Conjugated Retinoic Acid Receptor beta Rabbit mAb

Conjugated Retinoic Acid Receptor beta Rabbit mAb (catalogue number C56343) is a recombinant rabbit-derived conjugated primary antibody, reactive with Human samples. It targets Retinoic acid receptor beta (RARB): Receptor for retinoic acid. Supplied as 100ul at ₪1,627.49; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Conjugated Primary AntibodyHostRecombinant RabbitConjugateAF Dye
Host / source
Recombinant Rabbit
Reactivity
Human
Conjugate
AF Dye
UniProt ID
P10826
Gene
RARB
Target organism
Homo sapiens
Catalogue number
C56343
Brand
LABO Scientific
Storage
Store at 4˚Cin dark for 6 months

Target background

Target: Retinoic acid receptor beta (RARB) · Homo sapiens

Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence or presence of hormone ligand, acts mainly as an activator of gene expression due to weak binding to corepressors.

Subcellular location: Nucleus; Cytoplasm

Tissue specificity: Expressed in aortic endothelial cells (at protein level)

Sequence length: 455 aa · 50489 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at 4˚Cin dark for 6 months
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.